Boston Scientific's Troubled Waters: A Cautionary Tale for Medical Device Stocks Boston Scientific's stock price has plummeted 49. 6% year to date and 54.
4% over the past 52 weeks, outpacing its rivals in the medical device industry.
Despite its market dominance, the company's shares have underperformed the State Street SPDR S&P Health Care Equipment ETF by a wide margin. Boston Scientific's woes can be attributed to a perfect storm of challenges.